Natural selection for genetic variants in sport: The role of Y chromosome genes in Elite Female Athletes with 46,XY DSD

Sports Medicine

Volumn 44, Issue 12, 2014, Pages 1629-1634

  Ferguson Smith, Malcolm A ^a   Bavington, L Dawn ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ATHLETE; ATHLETIC PERFORMANCE; BODY HEIGHT; DISORDER OF SEX DEVELOPMENT; FEMALE; GENETICS; HUMAN; HYPERANDROGENISM; PHYSIOLOGY; SPORT; Y CHROMOSOMAL INHERITANCE;

ATHLETES; ATHLETIC PERFORMANCE; BODY HEIGHT; DISORDERS OF SEX DEVELOPMENT; FEMALE; GENES, Y-LINKED; HUMANS; HYPERANDROGENISM; SPORTS;

EID: 84911478378     PISSN: 01121642     EISSN: 11792035     Source Type: Journal    
DOI: 10.1007/s40279-014-0249-8     Document Type: Editorial

References (47)

1. International Olympic Committee. IOC regulations on female hyperandrogenism. 2012. http://www.olympic.org.
2. International Association of Athletics Federations. IAAF regulations governing eligibility of females with hyperandrogenism to complete in women’s competition. 2011. http://www.iaaf.org.
3. Heggie V. Testing sex and gender in sports; reinventing, reimagining and reconstructing histories. Endeavour. 2010;34:157–63.
4. Elsas LJ, Ljungqvist A, Ferguson-Smith MA, et al. Gender verification of female athletes. Genet Med Rep. 2000;2:249–54.
5. de la Chapelle A. The use and misuse of sex chromatin screening for “gender verification” of female athletes. JAMA. 1986;256:1920–3.
6. Simpson JL. Gender testing in the Olympics. JAMA. 1986;256:1938.
7. Ferguson-Smith MA, Ferris EA. Gender verification in sport: the need for change? Br J Sports Med. 1991;25:17–20.
8. Ljungqvist A, Simpson JL. Medical examination for health of all athletes replacing the need for gender verification in international sports. JAMA. 1992;267:150–2.
9. Simpson JL, Ljungqvist A, de la Chapelle A, et al. Gender verification in competitive sports. Sports Med. 1993;16:305–15.
10. Elsas LJ, Hayes RP, Muralidharan K. Genetic verification at the Centennial Olympic Games. J Med Assoc Ga. 1997;86:50–4.
11. Ferguson-Smith MA. Gender verification and the place of XY females in sport. In: Harries M, Williams C, Stanish WD, Micheli LJ, editors. Oxford Textbook of Sports Medicine. 2nd ed. Oxford: Oxford University Press; 1998. p. 355–365.
12. Martinez-Patino MJ. Personal account: a woman: tried and tested. Lancet. 2005;366(Sup l.23):38–9.
13. Ferguson-Smith MA. Correspondence. Archives, Glasgow University; 1970.
14. Press releases of the IOC. Games of the XXth Olympiad. Olymp Rev. 1972;59:389–92.
15. Hughes IA, Houk C, Ahmed SF, et al. Consensus statement on management of intersex disorders. Arch Dis Child. 2006;91:554–63.
16. Jordan-Young R, Sönksen P, Karkazis K. Sex, health, and athletes. Br Med J. 2014. doi:10.1136/bmj.g2926.
17. Bhasin S, Storer TW, Berman N, et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Eng J Med. 1996;335:1–7.
18. Bhasin S, Woodhouse L, Casaburi R, et al. Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab. 2001;281:E1172–81.
19. Healy ML, Gibney J, Pentecost C, et al. Endocrine profiles in 693 elite athletes in the post-competition setting. Clin Endocrinol. 2014. doi:10.1111/cen.12445
20. Karkazis K, Jordan-Young R, Davis G, et al. Out of bounds? A critique of the new policies on hyperandrogenism in elite female athletes. Am J Bioeth. 2012;7:3–16.
21. Karkazis K, Jordan-Young R. The Harrison Bergeron Olympics. Am J Bioeth. 2013;13:66–9.
22. Sailors P, Teetzel S, Weaving C. The complexities of sport, gender, and drug testing. Am J Bioeth. 2012;7:23–5.
23. Clark AG. The vital Y chromosome. Nature. 2014;508:463–5.
24. Fénichel P, Paris F, Philibert P, et al. Molecular diagnosis of 5α-reductase deficiency in 4 elite young female athletes through hormonal screening for hyperandrogenism. J Clin Endocrin Metab. 2013. doi:10.1210/jc.2012-3893.
25. Ferguson-Smith MA, Cooke A, Affara NA, et al. Genotype–phenotype correlations in XX males and their bearing on current theories of sex determination. Hum Genet. 1990;84:198–202.
26. Ferguson-Smith MA. Genotype–phenotype correlations in individuals with disorders of sex determination and development including Turner’s syndrome. Semin Dev Biol. 1991;2:265–76.
27. Ogata T, Matsuo N, The Y. Specific growth gene(s): how does it promote stature. J Med Genet. 1997;34:323–5.
28. Nielsen J. Klinefelter’s syndrome and the XYY syndrome. Acta Psychiatr Scand Suppl. 1969;45:209.
29. Gualdi-Russo E, Zaccagni L. Somatotype, role, and performance in elite volleyball players. J Sports Med Phys Fitness. 2001;41:256–62.
30. Leone M, Lariviere G, Comtois AS. Discriminant analysis of anthropometric and biomotor variables among elite adolescent female athletes in four sports. J Sports Sci. 2002;20:443–9.
31. Baylos IA, Bergeles NK, Apostolidis NG, et al. Anthropometric, body composition and somatotype differences of Greek elite female basketball, volleyball and handball players. J Sports Med Phys Fitness. 2006;46:271–80.
32. Tanner JM, Prader A, Habich H, et al. Genes on the Y chromosome influencing rate of maturation in man. Lancet. 1959;22:141–4.
33. Reeser JC. Gender identity: is the playing field level? Br J Sports Med. 2005;39:695–9.
34. Ostrander EA, Huson HJ, Ostrander GK. Genetics of athletic performance. Ann Rev Genomics Hum Genet. 2009;10:407–29.
35. Sutherland M, Langer B, Wassersug R. Getting a leg up on the competition: the importance of osteology in elite athletics. Am J Bioeth. 2012;7:25–7.
36. Shani R, Yechiel M. Excellence, deviance, and gender: lessons from the XYY episode. Am J Bioeth. 2012;7:27–30.
37. Camporesi S, Maugeri P. Caster Semenya: sport, categories and the creative role of ethics. J Med Eth. 2010;36:378–9.
38. Vilain E, Sanchéz FJ. Athletes’ bodies, sexed bodies—intersexuality in athletics. Nat Rev Endocrinol. 2012;8:198–9.
39. American Association of Clinical Endocrinologists. Medical guidelines for clinical practice for the diagnosis and treatment of hyperandrogenetic disorders. Endocr Pract. 2001;7:121–34.
40. Hagmar M, Berglund B, Brismar K, Hirschberg AL. Hyperandrogenism may explain reproductive dysfunction in Olympic athletes. Med Sci Sports Exerc. 2009;6:1241–8.
41. Bermon S, Ritzén M, Hirschberg AL, Murray TH. Are the new policies on hyperandrogenism in elite female athletes really out of bounds? Response to “Out of bounds a critique of the new policies on hyperandrogenism in elite female athletes”. Am J Bioeth. 2013;13:63–5.
42. New MI. Inborn errors of adrenal steroidogenesis. Mol Cell Endocrinol. 2003;211:75–83.
43. Eliakim A, Cale-Benzoor M, Klinger-Cantor B, et al. A case study of virilizing adrenal tumour in an adolescent female elite tennis player: insight into the use of anabolic steroids in young athletes. J Strength Cond Res. 2011;25:46–50.
44. International Association of Athletics Federations. IAAF regulations governing eligibility of athletes who have undergone sex reassignment to complete in women’s competition. 2011. http://www.iaaf.org.
45. Viloria H, Martínez-Patino M. Reexamining rationales of “fairness”: An athlete and insider’s perspective on the new policies on hyperandrogenism in elite female athletes. Am J Bioeth. 2012;12:17–9.
46. Cooky C, Dworkin S. Policing the boundaries of sex: a critical examination of gender verification and the Caster Semenya controversy. J Sex Res. 2013;50:103–11.
47. Wonkam A, Fieggen K, Ramesar R. Beyond the Caster Semenya Controversy: the case of the use of genetics for gender testing in sports. J Genet Couns. 2010;19:545–8.